Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 all comers meta-analysis

Cai -FAVIPIRAVIR, 2020
 
ChiCTR2000029600
NRainterferonlopinavir/ritonavirCOVID 19 all comersNA
35/45 suggested
  • suggested 5.5-fold increase in clinical improvement,clinical improvement (14-day)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).